Methods: Since 2008 we investigated 395 patients (11.4±5.5 y) with suspected MFS. In 145 patients MFS was diagnosed, thereby 16 patients showed BAV. We retrospectively analyzed correlation of prevalence and age of onset of cardiovascular pathologies (Dilatation sinus of valsalvae (SV), Mitral valve prolaps (MVP)), systemic manifestation of Ghent Criteria and FBN1 mutation with appearance of BAV.
Results: Prevalence of BAV in pediatric Marfan patients was 11.0 % whereas age of patients with and without BAV did not differ significantly. There is no correlation of BAV with prevalence or age of onset of pathologies of MFS. (Table1).
Table1: Correlation of Marfan pathologies with BAV appearance. Conclusions: In our large collective prevalence of BAV in MFS was surprisingly higher compared to adult. The reason is unknown, but can possibly be an effect of selection. Indeed, occurrence of BAV did not correlate with severity of clinical phenotype. Especially SV dilatation did not appear earlier or more often in BAV patients. Thus BAV is present frequently in MFS but is no predictor for clinical outcome and estimation of need for therapy. Development of pathologies in those patients in adulthood is unknown but may be relevant for course of disease. Good predictors for severity of phenotype in childhood are unfortunately still missing.
